UBE2L3 has been previously reported to be associated with increased risk for SLE,38,39,40 Crohn disease (MIM: 266600),41 and HypoThy (where rs5754217 was identified as one of the risk variants),42 among other IMDs. Here, UBE2L3 is linked to systemic lupus erythematosus.